James T. Lee, PhD
James has extensive research, commercial, and strategic perspective on the pharmaceutical and biotech industries. He has a strong expertise in oncology, particularly immuno-oncology, where he has led many client engagements ranging from commercial opportunity assessments to portfolio/platform management. He has helped clients navigate many potential BD&L issues, ranging from in- and out-licensing opportunities and evaluating precommercial biotech clinical development paths.
Before joining Defined Health, James was a Scientist and Oncology Personalized Medicine Project Leader and was involved in numerous preclinical neuroscience and translational oncology projects at Psychogenics. During that time, he managed a diverse collaborative effort to discover and validate drug discovery and preclinical tools for both clients and patients. Previously he completed his postdoctoral fellowship at Columbia University in Oncology in the laboratory of Dr. Wei Gu working with tumor suppressors p53 and PTEN (in collaboration with Dr. Ramon Parsons).
He received a BA from Rutgers University, a PhD in Neuroscience from Emory University, where he studied the molecular mechanisms of Parkinson’s disease.